5. Högl B et al. Efficacy and safety of pramipexole for Restless Legs Syndrome: a 26 Week randomised, placebo-controlled clinical trial in the European Union. Poster # P07.056 presented on 30 April 2009 at the 61st Annual Meeting of the American Academy of Neurology, Seattle, U.S.A.
6. Phillips B et al. Epidemiology of Restless Legs Symptoms in adults. Arch Intern Med 2000; 160(14): 2137-2141.
7. Hening W et al. Impact, diagnosis and treatment of Restless Legs Syndrome in a primary care population: REST (RLS epidemiology, symptoms and treatment) primary care study. Sleep Med 2004; 5(3): 237-246.
Contact:
Ursula Bardon
Corporate Division Communications
Boehringer Ingelheim GmbH
55216 Ingelheim/Germany
E-mail: press@boehringer-ingelheim.com
Phone: +49-6132-77-2622
Contact: Ursula Bardon, Corporate Division Communications, Boehringer Ingelheim GmbH, 55216 Ingelheim/Germany, E-mail: press@boehringer-ingelheim.com, Phone: +49-6132-77-2622
